Esperion Therapeutics, Inc.
GB ˙ LSE ˙ US29664W1053
3,13 $ ↓ -0,00 (-0,16%)
2026-06-05
AKTIENPREIS
SecurityGB:0IIM / Esperion Therapeutics, Inc.
InstitutionState Street Corp
Latest Disclosed Ownership1,046,377 shares
Ownership 1.69%
State Street Corp ownership in 0IIM / Esperion Therapeutics, Inc.

2022-02-09 - State Street Corp has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,046,377 shares of Esperion Therapeutics, Inc. (GB:0IIM). This represents 1.69 percent ownership of the company. In their previous filing dated 2021-02-11 , State Street Corp had reported owning 2,522,544 shares, indicating a decrease of -58.52 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2022-02-09 2022-02-09 13G/A 2,522,544 1,046,377 -58.52 1.69 -81.33
2021-02-11 2021-02-11 13G 1,101,509 2,522,544 129.01 9.05 124.57
2020-02-14 2020-02-14 13G/A 1,507,249 1,101,509 -26.92 4.03 -28.04
2019-02-14 2019-02-14 13G 1,507,249 5.60

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 7,055,794 1,125,498 18.98 19,333 -11.89 0.0007
2026-02-13 2025-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 5,930,296 1,451,462 32.41 21,942 84.88 0.0007
2025-11-14 2025-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 4,478,834 720,112 19.16 11,869 220.76 0.0004
2025-08-14 2025-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 3,758,722 -789,526 -17.36 3,700 -43.50 0.0001
2025-05-15 2025-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 4,548,248 44,014 0.98 6,549 -33.91 0.0003
2025-02-14 2024-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 4,504,234 649,920 16.86 9,909 55.83 0.0004
2024-11-14 2024-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 3,854,314 99,802 2.66 6,360 -23.71 0.0003
2024-08-14 2024-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 3,754,512 3,203,263 581.09 8,335 464.32 0.0004
2024-05-15 2024-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 551,249 167,500 43.65 1,477 28.77 0.0001
2024-02-14 2023-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 383,749 81,300 26.88 1,147 287.50 0.0001
2023-11-14 2023-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 302,449 0 0.00 296 -29.52 0.0000
2023-08-14 2023-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 302,449 -1,600,965 -84.11 420 -86.12 0.0000
2023-05-15 2023-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 1,903,414 149,105 8.50 3,026 -72.31 0.0002
2023-05-15 2022-12-31 13F/A-99 ESPERION THERAPEUTICS INC NE COM 29664W105 1,754,309 221,161 14.43 10,929 6.40 0.0006
2023-05-15 2022-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 1,754,309 221,161 10,929 0.0006
2022-11-15 2022-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 1,533,148 288,609 23.19 10,272 29.78 0.0006
2022-08-15 2022-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 1,244,539 328,101 35.80 7,915 86.15 0.0005
2022-05-16 2022-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 916,438 -129,939 -12.42 4,252 -18.73 0.0002
2022-02-14 2021-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 1,046,377 469,096 81.26 5,232 -24.78 0.0002
2021-11-15 2021-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 577,281 -1,674,913 -74.37 6,956 -85.40 0.0004
2021-08-16 2021-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 2,252,194 133,748 6.31 47,634 -19.84 0.0025
2021-07-09 2021-03-31 13F/A-1 ESPERION THERAPEUTICS INC NE COM 29664W105 2,118,446 -404,098 -16.02 59,422 -9.40 0.0034
2021-05-17 2021-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 2,118,446 -404,098 59,422 0.0034
2021-02-16 2020-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 2,522,544 719,794 39.93 65,586 -2.12 0.0040
2020-11-10 2020-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 1,802,750 55,054 3.15 67,008 -25.28 0.0046
2020-08-14 2020-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 1,747,696 641,079 57.93 89,674 157.00 0.0065
2020-06-19 2020-03-31 13F/A-1 ESPERION THERAPEUTICS INC NE COM 29664W105 1,106,617 5,108 0.46 34,892 -46.88 0.0031
2020-05-11 2020-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 1,106,617 5,108 34,892 3,064.2202
2020-02-06 2019-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 1,101,509 -340,851 -23.63 65,683 24.22 0.0045
2019-11-14 2019-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 1,442,360 -150,621 -9.46 52,877 -28.65 0.0039
2019-08-14 2019-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 1,592,981 204,891 14.76 74,105 32.97 0.0055
2019-05-15 2019-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 1,388,090 -119,159 -7.91 55,732 -19.62 0.0043
2019-02-12 2018-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 1,507,249 -338,559 -18.34 69,333 -15.34 0.0063
2018-11-09 2018-09-30 13F ESPERION THERAPEUTICS Common equity shares 29664W105 1,845,808 -327,929 -15.09 81,899 -3.86 0.0063
2018-08-14 2018-06-30 13F ESPERION THERAPEUTICS Common equity shares 29664W105 2,173,737 859,024 65.34 85,191 -10.41 0.0071
2018-05-15 2018-03-31 13F ESPERION THERAPEUTICS Common equity shares 29664W105 1,314,713 145,881 12.48 95,091 23.56 0.0081
2018-02-14 2017-12-31 13F ESPERION THERAPEUTICS Common equity shares 29664W105 1,168,832 -91,582 -7.27 76,961 21.84 0.0062
2017-11-14 2017-09-30 13F ESPERION THERAPEUTICS Common equity shares 29664W105 1,260,414 -246,100 -16.34 63,166 -9.40 0.0055
2017-08-14 2017-06-30 13F ESPERION THERAPEUTICS Common equity shares 29664W105 1,506,514 1,093,292 264.58 69,721 377.80 0.0062
2017-05-15 2017-03-31 13F ESPERION THERAPEUTICS Common equity shares 29664W105 413,222 174,740 73.27 14,592 388.19 0.0013
2017-02-09 2016-12-31 13F ESPERION THERAPEUTICS Common equity shares 29664W105 238,482 -5,264 -2.16 2,989 -11.49 0.0003
2017-01-13 2016-09-30 13F/A-1 ESPERION THERAPEUTICS Common equity shares 29664W105 243,746 -2,525 -1.03 3,377 38.52 0.0003
2016-11-14 2016-09-30 13F ESPERION THERAPEUTICS Common equity shares 29664W105 243,746 3,377
2016-08-12 2016-06-30 13F ESPERION THERAPEUTICS Common equity shares 29664W105 246,271 -2,557 -1.03 2,438 -42.05 0.0003
2016-05-20 2016-03-31 13F/A-1 ESPERION THERAPEUTICS Common equity shares 29664W105 248,828 -828,638 -76.91 4,207 -82.46 0.0005
2016-05-12 2016-03-31 13F ESPERION THERAPEUTICS Common equity shares 29664W105 248,828 4,207
2016-02-16 2015-12-31 13F ESPERION THERAPEUTICS Common equity shares 29664W105 1,077,466 349,589 48.03 23,983 39.65 0.0026
2015-11-16 2015-09-30 13F ESPERION THERAPEUTICS Common equity shares 29664W105 727,877 205,457 39.33 17,174 -59.79 0.0020
2015-08-13 2015-06-30 13F ESPERION THERAPEUTICS Common equity shares 29664W105 522,420 129,572 32.98 42,712 17.41 0.0046
2015-05-15 2015-03-31 13F ESPERION THERAPEUTICS Common equity shares 29664W105 392,848 316,922 417.41 36,379 1,085.76 0.0037
2015-02-11 2014-12-31 13F ESPERION THERAPEUTICS Common equity shares 29664W105 75,926 27,872 58.00 3,068 161.11 0.0003
2014-11-12 2014-09-30 13F/A-1 ESPERION THERAPEUTICS Common equity shares 29664W105 48,054 6,451 15.51 1,175 78.03 0.0001
2014-11-10 2014-09-30 13F ESPERION THERAPEUTICS Common equity shares 29664W105 48,054 1,175
2014-08-12 2014-06-30 13F ESPERION THERAPEUTICS Common equity shares 29664W105 41,603 1,560 3.90 660 8.55 0.0001
2014-05-15 2014-03-31 13F/A-1 ESPERION THERAPEUTICS Common equity shares 29664W105 40,043 2,510 6.69 608 17.83 0.0001
2014-05-13 2014-03-31 13F ESPERION THERAPEUTICS Common equity shares 29664W105 40,043 608
2014-02-06 2013-12-31 13F/A-1 ESPERION THERAPEUTICS Common equity shares 29664W105 37,533 7,333 24.28 516 -9.31 0.0001
2013-11-12 2013-09-30 13F ESPERION THERAPEUTICS Common equity shares 29664W105 30,200 30,200 569 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.